Skip to main content

Table 4 Relation between SUVmax and histopathological criteria of tumor

From: Bronchogenic carcinoma: the added value of FDG PET/CT advanced volumetric and metabolic parameters in initial evaluation and their impact on prognosis and clinical outcome

  

SUVmax

Test value

P value

Mean

SD

Side

Right

13.43

5.27

2.28*

0.04

 

Left

7.60

3.51

  

Site

Upper lobe

11.33

5.59

0.86*

0.40

 

Middle/lower lobe

14.00

5.03

  

Histopathological grade

Grade 2

7.22a

2.77

18.80**

 < 0.001

 

Grade 3

15.33b

3.06

  
 

Grade 4

16.43b

3.64

  

Histopathology

Adenocarcinoma

12.44

5.34

1.00*

0.33

 

Other types

9.00

6.24

  

T staging

T1/T2

6.14

1.95

6.07*

 < 0.001

 

T3/T4

15.25

3.65

  

LN

Negative

8.44

4.19

3.23*

0.01

 

Positive

15.00

4.62

  

M staging

M0

9.18

4.77

3.09*

0.01

 

M1

15.63

4.07

  

Pathological stage

1a3

6.00a

2.10

12.42**

0.001

 

3a

13.00b

4.24

  
 

4b

15.63b

4.07

  

Grade (cell diff)

Low (well differentiated)

6.25a

2.36

10.61**

0.001

 

Intermediate (moderately differentiated)

5.50a

2.12

  
 

High (poorly differentiated)

14.62b

4.17

  
  1. *Student's t-test **One-way ANOVA test (a,b: post hoc test)